Qube Research & Technologies LTD Pa Vmed Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.22 - $0.5 $0 - $2	4 New	4 $0
Q3 2022 Nov 14, 2022	SELL	$0.57 - $34.65 $3,781 - $229,868	-6,634 Reduced 10.4%	57,130 $49,000
Q2 2022 Aug 15, 2022	BUY	$0.85 - $1.41 $54,199 - $89,907	63,764 New	63,764 $60,000
Q1 2022 May 09, 2022	SELL	$1.16 - $2.5 $111,975 - $241,327	-96,531 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$2.46 - $8.74 $174,443 - $619,770	70,912 Added 276.79%	96,531 $237,000
Q3 2021 Nov 12, 2021	BUY	$5.1 - $9.39 $14,356 - $26,432	2,815 Added 12.34%	25,619 $219,000
Q2 2021 Aug 13, 2021	BUY	$3.95 - $6.88 $90,075 - $156,891	22,804 New	22,804 $146,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.